PHARMACYTE BIOTECH, INC. Effective Tax Rate
PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Tax Rate of 0.00% for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, percent for fiscal 2026 was 0.00%.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, percent for fiscal 2014 was 34.00%, a 0.00% change from fiscal 2013.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, percent for fiscal 2013 was 34.00%, a 0.00% change from fiscal 2012.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, percent for fiscal 2012 was 34.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|
| 2026-04-30 | 0.00% 10-K · filed 2026-07-29 |
| 2014-04-30 | 34.00% 10-K · filed 2014-08-04 |
| 2013-04-30 | 34.00% 10-K · filed 2014-08-04 |
| 2012-04-30 | 34.00% 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |